Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 452

1.

Long-lasting effects of methocinnamox on heroin self-administration in rhesus monkeys.

Maguire DR, Gerak LR, Woods JH, Husbands SM, Disney A, France CP.

J Pharmacol Exp Ther. 2018 Nov 6. pii: jpet.118.252353. doi: 10.1124/jpet.118.252353. [Epub ahead of print]

2.

On the nature of directed behavior to drug-associated light cues in rhesus monkeys (Macaca mulatta).

Reilly MP, Berndt SI, Woods JH.

Behav Anal (Wash D C). 2016 Nov;16(4):200-209. doi: 10.1037/bar0000050.

3.

Obituary: Tomoji Yanagita, M.D., Ph.D. (1930-2016)-psychopharmacologist extraordinaire.

Woods JH, Takada K.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3827-3828. Epub 2016 Oct 6. No abstract available.

PMID:
27709250
4.

Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception.

Saccone PA, Lindsey AM, Koeppe RA, Zelenock KA, Shao X, Sherman P, Quesada CA, Woods JH, Scott PJ.

J Pharmacol Exp Ther. 2016 Nov;359(2):366-373. Epub 2016 Sep 13.

5.

Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys.

Saccone PA, Zelenock KA, Lindsey AM, Sulima A, Rice KC, Prinssen EP, Wichmann J, Woods JH.

J Pharmacol Exp Ther. 2016 Apr;357(1):17-23. doi: 10.1124/jpet.115.231134. Epub 2016 Jan 22.

6.

Effects of sex and remifentanil dose on rats' acquisition of responding for a remifentanil-conditioned reinforcer.

Bertz JW, Jackson EL, Barron DR, Woods JH.

Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):137-47. doi: 10.1097/FBP.0000000000000205.

7.

Effects of pramipexole on the acquisition of responding with opioid-conditioned reinforcement in the rat.

Bertz JW, Chen J, Woods JH.

Psychopharmacology (Berl). 2015 Jan;232(1):209-21. doi: 10.1007/s00213-014-3659-2. Epub 2014 Jul 3.

8.

A thermostable bacterial cocaine esterase rapidly eliminates cocaine from brain in nonhuman primates.

Howell LL, Nye JA, Stehouwer JS, Voll RJ, Mun J, Narasimhan D, Nichols J, Sunahara R, Goodman MM, Carroll FI, Woods JH.

Transl Psychiatry. 2014 Jul 1;4:e407. doi: 10.1038/tp.2014.48.

9.

An mHealth model to increase clinic attendance for breast symptoms in rural Bangladesh: can bridging the digital divide help close the cancer divide?

Ginsburg OM, Chowdhury M, Wu W, Chowdhury MT, Pal BC, Hasan R, Khan ZH, Dutta D, Saeem AA, Al-Mansur R, Mahmud S, Woods JH, Story HH, Salim R.

Oncologist. 2014 Feb;19(2):177-85. doi: 10.1634/theoncologist.2013-0314. Epub 2014 Jan 6.

10.

Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice.

Kishioka S, Kiguchi N, Kobayashi Y, Yamamoto C, Saika F, Wakida N, Ko MC, Woods JH.

Neurosci Lett. 2013 Sep 27;552:98-102. doi: 10.1016/j.neulet.2013.07.040. Epub 2013 Aug 7.

PMID:
23933210
11.

Acquisition of responding with a remifentanil-associated conditioned reinforcer in the rat.

Bertz JW, Woods JH.

Psychopharmacology (Berl). 2013 Sep;229(2):235-43. doi: 10.1007/s00213-013-3102-0. Epub 2013 Apr 23.

12.

Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats.

Jutkiewicz EM, Rice KC, Carroll FI, Woods JH.

Drug Alcohol Depend. 2013 Aug 1;131(3):284-97. doi: 10.1016/j.drugalcdep.2012.12.021. Epub 2013 Jan 18.

13.

Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects.

Moynihan HA, Derrick I, Broadbear JH, Greedy BM, Aceto MD, Harris LS, Purington LC, Thomas MP, Woods JH, Traynor JR, Husbands SM, Lewis JW.

J Med Chem. 2012 Nov 26;55(22):9868-74. doi: 10.1021/jm301096s. Epub 2012 Oct 31.

14.

Self-administration of agonists selective for dopamine D2, D3, and D4 receptors by rhesus monkeys.

Koffarnus MN, Collins GT, Rice KC, Chen J, Woods JH, Winger G.

Behav Pharmacol. 2012 Aug;23(4):331-8. doi: 10.1097/FBP.0b013e3283564dbb.

15.

Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.

Collins GT, Brim RL, Noon KR, Narasimhan D, Lukacs NW, Sunahara RK, Woods JH, Ko MC.

J Pharmacol Exp Ther. 2012 Jul;342(1):205-13. doi: 10.1124/jpet.112.194639. Epub 2012 Apr 19.

16.

Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination.

Lee TY, Park YS, Garcia GA, Sunahara RK, Woods JH, Yang VC.

Mol Pharm. 2012 May 7;9(5):1361-73. doi: 10.1021/mp200623w. Epub 2012 Mar 28.

17.

Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction.

Narasimhan D, Woods JH, Sunahara RK.

Future Med Chem. 2012 Feb;4(2):137-50. doi: 10.4155/fmc.11.194. Review.

18.

Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats.

Collins GT, Narasimhan D, Cunningham AR, Zaks ME, Nichols J, Ko MC, Sunahara RK, Woods JH.

Neuropsychopharmacology. 2012 Apr;37(5):1092-103. doi: 10.1038/npp.2011.226. Epub 2011 Oct 12.

19.

The fate of bacterial cocaine esterase (CocE): an in vivo study of CocE-mediated cocaine hydrolysis, CocE pharmacokinetics, and CocE elimination.

Brim RL, Noon KR, Collins GT, Stein A, Nichols J, Narasimhan D, Ko MC, Woods JH, Sunahara RK.

J Pharmacol Exp Ther. 2012 Jan;340(1):83-95. doi: 10.1124/jpet.111.186049. Epub 2011 Oct 11.

20.

Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety.

Jimenez-Gomez C, Osentoski A, Woods JH.

Behav Pharmacol. 2011 Oct;22(7):711-3. doi: 10.1097/FBP.0b013e32834afebe.

21.

Subunit stabilization and polyethylene glycolation of cocaine esterase improves in vivo residence time.

Narasimhan D, Collins GT, Nance MR, Nichols J, Edwald E, Chan J, Ko MC, Woods JH, Tesmer JJ, Sunahara RK.

Mol Pharmacol. 2011 Dec;80(6):1056-65. doi: 10.1124/mol.111.074997. Epub 2011 Sep 2.

22.

The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry.

Brim RL, Noon KR, Collins GT, Nichols J, Narasimhan D, Sunahara RK, Woods JH.

Mol Pharmacol. 2011 Dec;80(6):1119-27. doi: 10.1124/mol.111.074534. Epub 2011 Sep 1.

23.

Individual differences in discount rate are associated with demand for self-administered cocaine, but not sucrose.

Koffarnus MN, Woods JH.

Addict Biol. 2013 Jan;18(1):8-18. doi: 10.1111/j.1369-1600.2011.00361.x. Epub 2011 Aug 4.

24.

Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs.

Brim RL, Noon KR, Nichols J, Narasimhan D, Woods JH, Sunahara RK.

Drug Alcohol Depend. 2011 Dec 15;119(3):224-8. doi: 10.1016/j.drugalcdep.2011.06.018. Epub 2011 Jul 19.

25.

Patterns of nicotinic receptor antagonism: nicotine discrimination studies.

Jutkiewicz EM, Brooks EA, Kynaston AD, Rice KC, Woods JH.

J Pharmacol Exp Ther. 2011 Oct;339(1):194-202. doi: 10.1124/jpet.111.182170. Epub 2011 Jul 5.

26.

Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats.

Collins GT, Cunningham AR, Chen J, Wang S, Newman AH, Woods JH.

Psychopharmacology (Berl). 2012 Jan;219(1):123-35. doi: 10.1007/s00213-011-2382-5. Epub 2011 Jun 24.

27.

Effects of selective dopaminergic compounds on a delay-discounting task.

Koffarnus MN, Newman AH, Grundt P, Rice KC, Woods JH.

Behav Pharmacol. 2011 Aug;22(4):300-11. doi: 10.1097/FBP.0b013e3283473bcb.

28.

Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats.

Collins GT, Zaks ME, Cunningham AR, St Clair C, Nichols J, Narasimhan D, Ko MC, Sunahara RK, Woods JH.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):158-65. doi: 10.1016/j.drugalcdep.2011.03.015. Epub 2011 Apr 11.

29.

Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase.

Collins GT, Carey KA, Narasimhan D, Nichols J, Berlin AA, Lukacs NW, Sunahara RK, Woods JH, Ko MC.

Neuropsychopharmacology. 2011 Apr;36(5):1047-59. doi: 10.1038/npp.2010.242. Epub 2011 Feb 2.

30.

Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity.

Collins GT, Truong YN, Levant B, Chen J, Wang S, Woods JH.

Psychopharmacology (Berl). 2011 Jun;215(4):609-20. doi: 10.1007/s00213-010-2154-7. Epub 2011 Jan 5.

31.

Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys.

Jimenez-Gomez C, Winger G, Dean RL, Deaver DR, Woods JH.

Behav Pharmacol. 2011 Feb;22(1):87-90. doi: 10.1097/FBP.0b013e3283423d55.

32.

Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists.

Pichika R, Jewett DM, Sherman PS, Traynor JR, Husbands SM, Woods JH, Kilbourn MR.

Nucl Med Biol. 2010 Nov;37(8):989-96. doi: 10.1016/j.nucmedbio.2010.06.002. Epub 2010 Jul 24.

33.

Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine.

Xue L, Ko MC, Tong M, Yang W, Hou S, Fang L, Liu J, Zheng F, Woods JH, Tai HH, Zhan CG.

Mol Pharmacol. 2011 Feb;79(2):290-7. doi: 10.1124/mol.110.068494. Epub 2010 Oct 22.

34.

A choice procedure to assess the aversive effects of drugs in rodents.

Podlesnik CA, Jimenez-Gomez C, Woods JH.

J Exp Anal Behav. 2010 Mar;93(2):203-23. doi: 10.1901/jeab.2010.93-203.

35.

Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.

Fantegrossi WE, Simoneau J, Cohen MS, Zimmerman SM, Henson CM, Rice KC, Woods JH.

J Pharmacol Exp Ther. 2010 Dec;335(3):728-34. doi: 10.1124/jpet.110.172247. Epub 2010 Sep 21.

36.

The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys.

Podlesnik CA, Ko MC, Winger G, Wichmann J, Prinssen EP, Woods JH.

Psychopharmacology (Berl). 2011 Jan;213(1):53-60. doi: 10.1007/s00213-010-2012-7. Epub 2010 Sep 18.

37.

Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats.

Cooper ZD, Shi YG, Woods JH.

Psychopharmacology (Berl). 2010 Oct;212(3):369-78. doi: 10.1007/s00213-010-1966-9. Epub 2010 Aug 5.

38.

Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats.

Li SM, Collins GT, Paul NM, Grundt P, Newman AH, Xu M, Grandy DK, Woods JH, Katz JL.

Behav Pharmacol. 2010 May;21(3):171-81. doi: 10.1097/FBP.0b013e32833a5c68.

39.

Structural analysis of thermostabilizing mutations of cocaine esterase.

Narasimhan D, Nance MR, Gao D, Ko MC, Macdonald J, Tamburi P, Yoon D, Landry DM, Woods JH, Zhan CG, Tesmer JJ, Sunahara RK.

Protein Eng Des Sel. 2010 Jul;23(7):537-47. doi: 10.1093/protein/gzq025. Epub 2010 Apr 30.

40.

A thermally stable form of bacterial cocaine esterase: a potential therapeutic agent for treatment of cocaine abuse.

Brim RL, Nance MR, Youngstrom DW, Narasimhan D, Zhan CG, Tesmer JJ, Sunahara RK, Woods JH.

Mol Pharmacol. 2010 Apr;77(4):593-600. doi: 10.1124/mol.109.060806. Epub 2010 Jan 19.

41.

PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity.

Park JB, Kwon YM, Lee TY, Brim R, Ko MC, Sunahara RK, Woods JH, Yang VC.

J Control Release. 2010 Mar 3;142(2):174-9. doi: 10.1016/j.jconrel.2009.10.015. Epub 2009 Oct 24.

42.

14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. Further examples of pseudoirreversible mu opioid receptor antagonists.

Nieland NP, Rennison D, Broadbear JH, Purington L, Woods JH, Traynor JR, Lewis JW, Husbands SM.

J Med Chem. 2009 Nov 12;52(21):6926-30. doi: 10.1021/jm901074a.

43.

Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats.

Wood SK, Narasimhan D, Cooper Z, Sunahara RK, Woods JH.

Drug Alcohol Depend. 2010 Jan 15;106(2-3):219-29. doi: 10.1016/j.drugalcdep.2009.09.001. Epub 2009 Oct 1.

44.

Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats.

Collins GT, Brim RL, Narasimhan D, Ko MC, Sunahara RK, Zhan CG, Woods JH.

J Pharmacol Exp Ther. 2009 Nov;331(2):445-55. doi: 10.1124/jpet.108.150029. Epub 2009 Aug 26.

45.

Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats.

Collins GT, Woods JH.

Behav Pharmacol. 2009 Sep;20(5-6):492-504. doi: 10.1097/FBP.0b013e328330ad9b.

46.

Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.

Ko MC, Woods JH, Fantegrossi WE, Galuska CM, Wichmann J, Prinssen EP.

Neuropsychopharmacology. 2009 Aug;34(9):2088-96. doi: 10.1038/npp.2009.33. Epub 2009 Mar 11.

47.

14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity.

Moynihan H, Jales AR, Greedy BM, Rennison D, Broadbear JH, Purington L, Traynor JR, Woods JH, Lewis JW, Husbands SM.

J Med Chem. 2009 Mar 26;52(6):1553-7. doi: 10.1021/jm8012272.

48.

Effects of cocaine esterase following its repeated administration with cocaine in mice.

Ko MC, Narasimhan D, Berlin AA, Lukacs NW, Sunahara RK, Woods JH.

Drug Alcohol Depend. 2009 May 1;101(3):202-9. doi: 10.1016/j.drugalcdep.2009.01.002. Epub 2009 Feb 13.

49.

Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice.

Collins GT, Truccone A, Haji-Abdi F, Newman AH, Grundt P, Rice KC, Husbands SM, Greedy BM, Enguehard-Gueiffier C, Gueiffier A, Chen J, Wang S, Katz JL, Grandy DK, Sunahara RK, Woods JH.

J Pharmacol Exp Ther. 2009 Apr;329(1):210-7. doi: 10.1124/jpet.108.144048. Epub 2009 Jan 9.

50.

Narrowing in on compulsions: dopamine receptor functions.

Collins GT, Woods JH.

Exp Clin Psychopharmacol. 2008 Dec;16(6):498-502. doi: 10.1037/a0014190.

Supplemental Content

Loading ...
Support Center